COUNTRY
Finland

YEAR FOUNDED
2017

SECTOR
Healthtech

TECHNOLOGY
Big Data, Data analytics, Machine Learning

BUSINESS MODEL
B2B2C

REVENUE 2019
0 (pre-revenue)

NO. OF EMPLOYEES
1-9

FUNDING TYPES
Grants, Angel

FUNDING STAGE
Seed

TOTAL FUNDING RECEIVED
JPY 124 million

INVESTORS
PreSeed Ventures, Innofounder Experienced, Business Angels

WEBSITE
https://kamuhealth.com/

KAMU Health


Helping chronic respiratory patients monitor and manage their lung condition

KAMU Health has developed a digital tool that helps patients with chronic respiratory issues monitor their lung condition
from their home, enabling them better predict changes in their conditions and take proactive measures to address those
changes.

The solution improves the quality of life for patients by removing uncertainty and improves patient–doctor communication by sharing data with the doctor. KAMU Asthma combines accurate, clinical grade technology with a modern, mobile consumer experience.

KAMU Asthma is particularly relevant during the present COVID-19 pandemic, as it facilitates quality care in a time
when healthcare systems across the world are under extreme pressure. It also makes it possible for these very vulnerable
patients to self-isolate, as their need to visit clinics is strongly reduced.